Author:
Magrupov T. M.,Kuchkarova N. A.,Gaibnazarov S. S.
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Bell GS, Neligran A, Sander JW (2014) An unknown quantity—The worldwide prevalence of epilepsy. Epilepsia 55(7):958–962
2. (2019) GBD 2016 Epilepsy Collaborators Global, regional and national burden of epilepsy, 1990–2016: A systematic analysis for the Global Burden of Disease Study. Lancet Neurol 18:357–375
3. Epilepsy Factsheet WHO (2017) Updated February 2017 / http://www.who.int/mediacentre/factsheets/fs999/en. Accessed 3 February 2017
4. Azizova, R. B., Abdullayeva, N. N., and Usmonalieva, I. I., “Neuroimmunological characteristics of idiopathic and symptomatic epilepsy in accordance with the clinical course. Medico-legal update,” Ind. J. Forensic Med. Toxicol., 14, No. 4, 1377–1383 (2020).
5. Yuldashev ZM (2023) A remote system for monitoring the state of health of people with chronic diseases and predicting periods of exacerbation. Biomed Eng 56:294–297